In this episode, Caitlin Costello, MD, discusses important topics related to relapsed/refractory (R/R) multiple myeloma (MM), including: 3 bispecific antibodies approved for the treatment of R/R MM that target BCMA or GPRC5D The role of bispecific antibodies in R/R MM Safety considerations for patients while receiving a bispecific antibody Emerging data and clinical trials with bispecific antibodies Key clinical pearls for optimal use of bispecific antibodies Presenter: Caitlin Costello, MD Clinical Professor of Medicine Director, Multiple Myeloma Program Division of Blood and Marrow Transplantation Moores Cancer Center UC San Diego La Jolla, California Link to full program: https://bit.ly/40bjFCZ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
